Special Issue "Principles, Limitations, and Recent Progress in 3D Printing for Pharmaceutical Applications"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 171
There has been an increasing interest in applying 3D printing to the manufacture of various forms of drugs or drug delivery systems. Three-dimensional printing might offer potential advantages and new opportunities compared to conventional techniques, including the accurate control of active pharmaceutical ingredient (API) distribution, tailoring the macro- and microstructures of products to control dissolution or release kinetics, and the ability to fabricate single or multiple API doses for use in personalized or customized medication, without using a high volume of ingredients or needing a costly manufacturing facility. Although there is already a 3D-printed drug that has been approved by the FDA for oral medication, there are still many technical, regulatory, and even economic challenges to be surpassed before the widespread application and common use of 3D printing in pharmaceutical manufacturing. This Special Issue aims to explore the recent progress and limitations of using 3D printing in pharmaceutical applications. Original research articles and reviews on the development and usage of 3D printing in any dosage form (i.e., implants, tablets, edible substrate, microneedles), printing techniques (i.e., FDM, SLS, SLA, BJP), and drug or target applications are welcome. Research areas may include (but are not limited to) the innovation and refinement of fabrication techniques or the materials employed, the manufacturing of drug delivery systems, characterizations and performance appraisals of the fabricated dosages, and perspectives on their implementation potential in the pharmaceutical industry.
I/We look forward to receiving your contributions.
Dr. Jintamai Suwanprateeb
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- 3D printing
- additive manufacturing
- drug delivery/drug carrier
- drug release, disintegration and dissolution
- customized medication
- oral solid dosage forms
- drug loaded implants
- drug loaded microneedle